Troy Wichterman - 07 Jan 2022 Form 4/A - Amendment Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Financial Officer
Signature
/s/ Troy Wichterman
Issuer symbol
BLFS
Transactions as of
07 Jan 2022
Net transactions value
-$1,445
Form type
4/A - Amendment
Filing time
17 Feb 2022, 19:26:49 UTC
Date Of Original Report
11 Jan 2022
Previous filing
17 Feb 2022
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale $1,445 -47 -0.21% $30.75 22,075 07 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F2 On January 11, 2022, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares.